Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995;73(4):515-21.

Evaluation of commercial HTLV-1 test kits by a standard HTLV-1 serum panel

C Fujiyama  1 , T Fujiyoshi, D Matsumoto, H Tamashiro, S Sonoda
Affiliations

Evaluation of commercial HTLV-1 test kits by a standard HTLV-1 serum panel

C Fujiyama et al. Bull World Health Organ. 1995.

Abstract

To evaluate the performance of currently available test kits for human T-cell lymphotropic virus type 1 (HTLV-1), we examined two particle agglutination (PA) tests and nine enzyme immunoassays (EIA) using a standard serum panel consisting of HTLV-1-positive and HTLV-1-negative sera that had been characterized by immunofluorescence and the polymerase chain reaction (PCR). The PA kits exhibited 94.0-100.0% sensitivity and 99.5-100.0% specificity; the sensitivity range was ascribed to the quality of the HTLV-1 antigens coated on the particles. The EIA kits had 99.5-100% sensitivity and 98.5-100% specificity; the 98.5%-99.5% specificity exhibited by five of the EIA kits could have been due to nonspecific reactions that were detected through use of an inadequate cut-off value and the use of recombinant proteins. It can be concluded that the sensitivity of the currently available PA and EIA kits is sufficient to permit their use for screening purposes; however, the specificity of some EIA kits should be optimized.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. J Virol Methods. 1988 Oct;22(1):51-9 - PubMed
    1. AIDS Res Hum Retroviruses. 1993 Jun;9(6):495-8 - PubMed
    1. J Immunol. 1989 Feb 1;142(3):971-8 - PubMed
    1. Lancet. 1989 Feb 25;1(8635):441 - PubMed
    1. Jpn J Ophthalmol. 1989;33(1):1-12 - PubMed

Publication types

Substances

LinkOut - more resources